Growth Metrics

Baxter International (BAX) EBITDA Margin (2016 - 2024)

Baxter International (BAX) has disclosed EBITDA Margin for 16 consecutive years, with 34.83% as the latest value for Q4 2024.

  • On a quarterly basis, EBITDA Margin rose 1116.0% to 34.83% in Q4 2024 year-over-year; TTM through Dec 2024 was 30.18%, a 2336.0% increase, with the full-year FY2025 number at 2.74%, down 287.0% from a year prior.
  • EBITDA Margin was 34.83% for Q4 2024 at Baxter International, down from 38.27% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 38.27% in Q3 2024 to a low of 79.8% in Q3 2022.
  • A 5-year average of 8.29% and a median of 12.47% in 2020 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -9570bps in 2022, then skyrocketed 7784bps in 2023.
  • Baxter International's EBITDA Margin stood at 12.76% in 2020, then crashed by -94bps to 0.8% in 2021, then plummeted by -1142bps to 8.33% in 2022, then soared by 384bps to 23.67% in 2023, then skyrocketed by 47bps to 34.83% in 2024.
  • Per Business Quant, the three most recent readings for BAX's EBITDA Margin are 34.83% (Q4 2024), 38.27% (Q3 2024), and 38.27% (Q2 2024).